Department of Neurology

Kenneth J. Gaines, M.D., M.B.A., Chair

Doctor and patient discussing x-ray

Welcome

The Department of Neurology was created in May 2012 as part of a groundbreaking public-private partnership that unites the Dayton region’s most advanced biomedical research institution with the clinical resources of its largest hospital system. In 2010, Wright State University and Premier Health announced the creation of the Wright State & Premier Neuroscience Institute, a unique public-private partnership uniting the hospital system’s clinical resources with the university’s strengths in biomedical research. The Neuroscience Institute has talented, NIH-funded neuroscientists on the Wright State University campus, including a team awarded two prestigious Program Project Grants totaling more than $9 million from the National Institute of Neurological Disorders and Stroke, some of whom are included on the faculty of the Neurology Residency Program. The department’s main academic office and clinical facilities are housed in Premier hospitals.

The department is closely aligned with other programs including neurosurgery, physical medicine and rehabilitation and psychiatry. Areas of specialization in the neuroscience program include behavioral neurology, cerebrovascular disease, child neurology, clinical neurophysiology, critical care, epilepsy, movement disorders, neuroimaging, neuroimmunology, neuromuscular disease, neuro-oncology, neuro-ophthalmology, pain management, psychiatry and sleep disorders. The clinical faculty are integrated with basic science faculty at Wright State University.

Our Mission

  • To heal, lead, educate and innovate.

Our Vision

  • To provide comprehensive and innovative patient care services in general and sub-specialty areas of neurology;
  • To provide broadly based education to support physicians practicing in our community and to prepare our next generation of physicians and neurologists;
  • To engage in clinical, basic science and translational research to improve existing treatments and develop and implement new therapies for neurological disease; and
  • To foster community based activities providing support services and education programs for patients and families affected by neurological disease.